One year after launching the CMS Health Tech Ecosystem, officials convened in D.C. to celebrate the Trump administration ...
The big takeaway from the recent Alzheimer’s Association International Conference in London is an economic message: Dementia ...
The world risks a resurgence of the HIV epidemic after international financing to combat the disease suffered a “profound ...
Ahead of a hearing, the FDA raised questions about the benefits of a Duchenne treatment from Capricor Therapeutics, another ...
Emergency departments across America report dramatic increases in serious injuries from e-bikes and e-scooters,” write CHOP’s ...
Oak Hill Bio, a new company backed by RA Capital and other investors, will take on Ultragenyx and Ionis in developing an ...
Even as some medical schools heed health secretary Robert F. Kennedy Jr.’s call for more nutrition education, several told ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Sarepta Therapeutics, the bruised ...
Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Sarepta Therapeutics’ CEO Doug Ingram said ...
Chelsea covers the Department of Health and Human Services with a particular focus on power and influence at the top. Confidential tips can be sent via Signal at chelseacirruzzo.42. WASHINGTON — The ...
Federal health officials are investigating a new outbreak of the diarrhea-causing parasite. We don’t know where or which ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Argenx said Monday it would buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results